Effymed is a CRO company focused on customized disease models including oncology models CDX PDX and IO oncology models and biomarker initiatives. We also have many years of experience of ischemic stroke model (MCAO, middle cerebral artery occlusion).
Translational and in vivo pharmacology platforms are the key arears for preclinical drug evaluation. We have accumulative CRO experiences serving for 15 of the world top pharmaceutical companies and more than 100 biotech companies all over the world.
